Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry
Diane E. Brown(Museum of Boulder), S. Akoghlanian(Duke University), B. Binstadt(Amgen (United States)), Alis Burciu(Novartis (Switzerland)), Stephen J. Balevic(Duke University), Gil Amarilyo(University of California, San Francisco), Laura E. Schanberg(Duke University), Heather Benham(University of California, San Francisco), Elodie Aubrun(Novartis (Switzerland)), Harris Ahmed(Childhood Arthritis and Rheumatology Research Alliance), Anne Dennos(Duke University), K. Baszis(Childhood Arthritis and Rheumatology Research Alliance), William Bernal(King's College - North Carolina), E. Allenspach(Duke University), Rahel Schneider(Novartis (Switzerland)), Imelda Balboni(Stanford University), H. Bell-Brunson(University of California, San Francisco), Stacy P. Ardoin(The Ohio State University), Ellena Brooks, Anne Adams, Matthew L. Basiaga(Mayo Clinic in Florida), Alexis Boneparth(University of California, San Francisco), Timothy Beukelman(University of Alabama at Birmingham), L. Bermudez-Santiago(Duke University), Yukiko Kimura(Hackensack University Medical Center), Marie A. Amoruso(Duke University), Neta Dagan(Duke University), Mara L. Becker(Children's Mercy Hospital), Sheila T. Angeles‐Han(Cincinnati Children's Hospital Medical Center), S. Armendariz(University of Alabama at Birmingham), T. Bigley(University of California, San Francisco), Barbara P Blackmon, J. M. Bridges(Novartis (India)), Amita Bansal(Australian National University), A. AlBijadi(Childhood Arthritis and Rheumatology Research Alliance), Yuhan Li(Novartis (United States)), C. Aguiar Lapsia, Clifton Bingham(Childhood Arthritis and Rheumatology Research Alliance), E. Beil(Childhood Arthritis and Rheumatology Research Alliance), S. Ballinger(Hospital for Special Surgery), John F. Bohnsack(Childhood Arthritis and Rheumatology Research Alliance), M. Brothers(Childhood Arthritis and Rheumatology Research Alliance), C Black(The Royal Free Hospital), M. Blakley, Deepak Narayanswamy(Novartis (Switzerland))
Cited by 1
Related Papers
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
|The Journal of Clinical Endocrinology & Metabolism|2010|678
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287